Mérieux and Shire funds back NeuroPhage in $12.4 million round for Alzheimer's
02 March 2011
Nancy Faigen
Please Login to read the full article.
02 March 2011
Nancy Faigen
nNancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA declares Shire's Firazyr effective, safe for HAE ahead of panel
- Genzyme yet to confirm date of next Fabrazyme shipment
- In bone drug quandary, FDA seeks panel's advice on safety, 'drug holidays'
- Japan to improve blood products independence through merger of plasma producers
